Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,071 | 50,522 | 57,242 | 72,132 | 61,031 |
| Marketable Securities | 380,742 | 355,446 | 339,251 | 306,030 | 306,709 |
| Receivables | 32,467 | 41,496 | 37,090 | 31,474 | 30,036 |
| Inventories | 1,025 | 902 | 1,055 | 1,361 | 1,280 |
| TOTAL | $478,301 | $461,808 | $446,652 | $421,224 | $409,145 |
| Non-Current Assets | |||||
| PPE Net | 3,113 | 3,318 | 3,631 | 3,840 | 4,136 |
| Intangibles | 20,081 | 20,450 | 20,820 | 21,189 | 21,559 |
| Other Non-Current Assets | 92,297 | 94,191 | 96,542 | 96,938 | 98,616 |
| TOTAL | $115,491 | $117,959 | $120,993 | $121,967 | $124,311 |
| Total Assets | $593,792 | $579,767 | $567,645 | $543,191 | $533,456 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,438 | 31,820 | 31,788 | 26,105 | 31,509 |
| Accrued Expenses | N/A | N/A | 40,201 | 35,679 | N/A |
| Other current liabilities | 39,981 | 40,177 | N/A | N/A | N/A |
| TOTAL | $74,419 | $71,997 | $71,989 | $61,784 | $65,936 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 34,427 |
| Other Non-Current Liabilities | 14,445 | 14,449 | 14,436 | 13,780 | 14,254 |
| TOTAL | $14,445 | $14,449 | $14,436 | $13,780 | $14,254 |
| Total Liabilities | $88,864 | $86,446 | $86,425 | $75,564 | $80,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,907 | 55,712 | 55,638 | 55,564 | 54,883 |
| Common Shares | 56 | 56 | 56 | 56 | 55 |
| Retained earnings | -164,176 | -171,254 | -179,025 | -188,678 | -197,328 |
| Other shareholders' equity | -175 | 111 | 103 | 192 | 239 |
| TOTAL | $504,928 | $493,321 | $481,220 | $467,627 | $453,266 |
| Total Liabilities And Equity | $593,792 | $579,767 | $567,645 | $543,191 | $533,456 |